| HOME >> BIOLOGY >> TECHNOLOGY |
MBI captures clear, precise images, even for those with dense breast tissue. Unlike MRI, MBI is safe for those who have pacemakers, metal implants or other foreign bodies, and patients with renal challenges. It's also an option for those who are claustrophobic, have silicone implants, and for those whose weight or size exceeds the allowable limit for MRI.
For those with dense breast tissue, MBI's innovative technology will help reduce false positives and will outperform standard mammography. In addition, MBI is cost-effective and can safely and efficiently monitor the patient to track treatment effectiveness and to detect any signs of disease reoccurrence.
"We are extremely happy to be able to offer this exciting technology to those in our community," said Dr. Helmer. "MBI is one more powerful tool that will help us identify breast cancer early so we can provide the patient with the best treatment options and best outcome."
GE Healthcare's Discovery* NM750b Molecular Breast Imaging is available at Karmanos Cancer Center's Walt Comprehensive Breast Center in Detroit, making it the third location to offer this technology in the United States. GE Healthcare's Discovery* NM750b was first launched in globally in 2011.
"More than 1.2 million people annually are diagnosed with breast cancer worldwide," said Nathan Hermony, GE Healthcare Nuclear Medicine general manager. "Since 1965, GE Healthcare has made significant progress in providing solutions for breast cancer detection and diagnosis that really brings a change to people's lives. This technology is intended to improve early detection of breast cancer, especially in woman that are less likely to benefit from conventional mammography or who don't have access to MRI, as in cases of dense breasts where imaging results may be inconclusive.
"At GE Healthcare, we believe early detection is critical for improving breast canc
'/>"/>
| SOURCE Karmanos Cancer Institute Copyright©2012 PR Newswire. All rights reserved |